Dissociative Anesthesia: Further Pharmacologic Studies and First Clinical Experience with the Phencyclidine Derivative Cl‐581

HERE IS A definite need for safe and T potent intravenously administered anesthetics of short duration which combine analgesic and sleep-producing effects without significant cardiovascular and respiratory depression. Recently, a number of compounds related to phenylcyclohexylamine have aroused clinical interest because they appear to approach such requirements. Phencyclidine hydrochloride was the prototype of this group of agents. After preliminary laboratory studies1 its clinical usefulness as an anesthetic was investigated by Greifenstein and associates.2

[1]  E. Domino,et al.  NEUROBIOLOGY OF PHENCYCLIDINE (SERNYL), A DRUG WITH AN UNUSUAL SPECTRUM OF PHARMACOLOGICAL ACTIVITY. , 1964, International review of neurobiology.

[2]  G. Chen,et al.  The pharmacology of 1-(1-phenylcyclohexyl) piperidine-HCl. , 1959, The Journal of pharmacology and experimental therapeutics.

[3]  E. Domino,et al.  Visually Evoked Responses in Man: A Method for Measuring Cerebral Effects of Preanesthetic Medication , 1964, Anesthesiology.

[4]  G. Rosenbaum,et al.  Combined sernyl and sensory deprivation. , 1960, Comprehensive psychiatry.

[5]  F. Greifenstein,et al.  A STUDY OF A 1‐ARYL CYCLO HEXYL AMINE FOR ANESTHESIA* , 1958, Anesthesia and analgesia.